VitalHub Introduces Subsidiary Transforming Systems Ltd.’s COVID-19 Solution to the Canadian Marketplace
TORONTO, Sept. 28, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the […]
FTI Consulting and Compass Lexecon Professionals Lead Who’s Who Legal Consulting Experts Guide for Fifth Consecutive Year
WASHINGTON, Sept. 28, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that the firm and its Compass […]
Puyi Inc. Files Fiscal Year 2020 Annual Report on Form 20-F with the SEC and Hosts Conference Call
GUANGZHOU, China, Sept. 28, 2020 (GLOBE NEWSWIRE) — Puyi Inc. (“Puyi” or the “Company”) (NASDAQ: PUYI), a leading third-party wealth […]
Perceptron Announces Fiscal Fourth Quarter And Full-Year 2020 Results
PLYMOUTH, Mich., Sept. 28, 2020 (GLOBE NEWSWIRE) — Perceptron, Inc. (NASDAQ: PRCP), a leading global provider of 3D automated metrology […]
Freeline announces promotion of Romuald Corbau, Ph.D. to Chief Scientific Officer
LONDON, Sept. 28, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully […]
Perceptron Enters into Definitive Agreement to be Acquired by Atlas Copco
All-Cash Transaction Values Perceptron at an Equity Valuation of Approximately $68.9 million71% Premium to Equity Closing Price on September 25, […]
Glory Star Wins Award for Best Chinese Internet Media Service Stock
BEIJING, Sept. 28, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the […]
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test
JERSEY, Channel Islands, Sept. 28, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September […]
Sierra Bullets to Acquire Assets of Barnes Bullets
– Combination Creates the Leading Specialty Bullet and Ammunition Platform With a Runway to $100 Million in Sales and 25-30% […]
Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I
BOSTON and LONDON, Sept. 28, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced […]
